Search

Balakrishna L Lokeshwar

from North Augusta, SC
Age ~68
Get Report
Also known as:
Balakrishna Vinata Lokeshwar, Bal L Lokeshwar, Balakrishn A Lokeshwar, Balakrishn L Lokeshwar, Balakrishna L Lokesha, Balak Lokeshwar, Balakrish Lokeshwar, Balakrishna Lokeswar, Balakrishna R, Balakrishn R
Phone and address:
321 E Shoreline Dr, North Augusta, SC 29841
(305) 255-6091
Related to:
Soum Lokeshwar, 31Vinata B Lokeshwar, 63
Connected to:
Andrea J Lokey, 52Dave T Lokey, 41Ken L Lokey, 88Kirk W Lokey, 44Lila M Lokey, 73Mary A Lokey, 56Melodie A Lokey, 62Patricia A Lokey, 66Pete Lokey, 96Ricky Lokey, 32

Balakrishna Lokeshwar Phones & Addresses

  • 321 E Shoreline Dr, North Augusta, SC 29841 (305) 255-6091
  • 12615 112Th St, Miami, FL 33176 (305) 255-6091
  • Houston, TX
  • Saint Louis, MO

Publications

Us Patents

Method Of Inhibiting Cancer Growth

View page
US Patent:
6429204, Aug 6, 2002
Filed:
Apr 3, 2000
Appl. No.:
09/542402
Inventors:
Lorne M. Golub - Smithtown NY
Thomas F. McNamara - Morristown NY
Nungavaram S. Ramamurthy - Smithtown NY
Hsi-Ming Lee - Setauket NY
Sanford Simon - Stony Brook NY
Balakrishna L. Lokeshwar - Miami FL
Marie G. Selzer - Fort Lauderdale FL
Norman L. Block - Miami FL
Assignee:
University of Miami - Miami FL
International Classification:
A61K 3165
US Classification:
514152, 514153
Abstract:
The invention is a method of inhibiting a sarcoma, such as Kaposis sarcoma, in a mammal. The method employs 6-demethyl-6-deoxy-4-de(dimethylamino)tetracycline (CMT-3. ).

Method For Treating Meibomian Gland Disease

View page
US Patent:
6455583, Sep 24, 2002
Filed:
May 7, 1999
Appl. No.:
09/307182
Inventors:
Stephen C. Pflugfelder - Miami FL
Balakrishna L. Lokeshwar - Miami FL
Marie Selzer - Fort Lauderdale FL
Assignee:
The University of Miami - Miami FL
International Classification:
A01N 3734
US Classification:
514528, 514912
Abstract:
A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.

Method For Treating Meibomian Gland Disease

View page
US Patent:
20030114426, Jun 19, 2003
Filed:
Aug 22, 2002
Appl. No.:
10/225341
Inventors:
Stephen Pflugfelder - Miami FL, US
Balakrishna Lokeshwar - Miami FL, US
Marie Selzer - Fort Lauderdale FL, US
International Classification:
A61K031/65
US Classification:
514/152000
Abstract:
A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.

Methods For Prevention And Treatment Of Cancer

View page
US Patent:
20040087559, May 6, 2004
Filed:
Oct 28, 2003
Appl. No.:
10/695509
Inventors:
Gary Schwartz - Winston-Salem NC, US
Balakrishna Lokeshwar - Miami FL, US
Tai Chen - Sudbury MA, US
Lyman Whitlatch - Boston MA, US
Michael Holick - Sudbury MA, US
International Classification:
A61K031/59
US Classification:
514/167000
Abstract:
Methods for inhibiting, preventing, or treating cancer cell growth are disclosed. In one embodiment, the method comprises the step of administering to a patient an effective amount of a metabolic precursor of 1,25-dihydroxyvitamin D, or an analog or a derivative thereof, to increase levels of the metabolic precursor available to a target cell. In a preferred embodiment, the metabolic precursor is 25-hydroxyvitamin D.

Methods For Treating Ocular Rosacea

View page
US Patent:
20060154901, Jul 13, 2006
Filed:
Dec 7, 2005
Appl. No.:
11/297780
Inventors:
Stephen Pflugfelder - Miami FL, US
Balakrishna Lokeshwar - Miami FL, US
Marie Selzer - Fort Lauderdale FL, US
International Classification:
A61K 31/65
US Classification:
514152000
Abstract:
A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.

Methods And Compositions For Treating Meibomian Gland Disease

View page
US Patent:
20080214510, Sep 4, 2008
Filed:
Oct 11, 2007
Appl. No.:
11/974435
Inventors:
Stephen C. PFLUGFELDER - Miami FL, US
Balakrishna L. LOKESHWAR - Miami FL, US
Marie SELZER - Fort Lauderdale FL, US
International Classification:
A61K 31/165
A61P 27/02
US Classification:
514152
Abstract:
A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.

Method For Treating Meibomian Gland Disease

View page
US Patent:
20110039805, Feb 17, 2011
Filed:
Jul 21, 2010
Appl. No.:
12/841058
Inventors:
Stephen C. Pflugfelder - Miami FL, US
Balakrishna L. Lokeshwar - Miami FL, US
Marie Selzer - Fort Lauderdale FL, US
Assignee:
The University of Miami - Miami FL
International Classification:
A61K 31/65
A61P 27/02
US Classification:
514152
Abstract:
A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.

Method For Treating Meibomian Gland Disease

View page
US Patent:
20120088739, Apr 12, 2012
Filed:
Dec 1, 2011
Appl. No.:
13/309145
Inventors:
Stephen C. Pflugfelder - Miami FL, US
Balakrishna L. Lokeshwar - Miami FL, US
Marie Selzer - Fort Lauderdale FL, US
Assignee:
THE UNIVERSITY OF MIAMI - Miami FL
International Classification:
A61K 31/65
A61P 31/00
A61P 27/02
US Classification:
514152
Abstract:
A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.
Control profile
Balakrishna L Lokeshwar from North Augusta, SC, age ~68 Get Report